These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 575495)

  • 41. [Bradycardiac action of creatinol-O-phosphate and ouabain].
    Musso E
    Boll Soc Ital Cardiol; 1972; 17(11):1112-4. PubMed ID: 4681782
    [No Abstract]   [Full Text] [Related]  

  • 42. Serum and organ creatine phosphokinase alterations in exercise.
    Klosak JJ; Penney DG
    Environ Physiol Biochem; 1975; 5(6):408-12. PubMed ID: 1213030
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enzyme release after myocardial infarction: comparison of serial serum alpha-hydroxybutyrate dehydrogenase with creatine phosphokinase levels.
    Norris RM; Howell D; Whitlock RM; Heng MK; Peter T
    Eur J Cardiol; 1976 Dec; 4(4):461-8. PubMed ID: 1001339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Protective effect of glycine on hypoxic rat myocardial cells].
    Zhou JL; Huang YS; Dang YM; Zhang JP
    Zhonghua Shao Shang Za Zhi; 2005 Oct; 21(5):329-32. PubMed ID: 16383030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Anti-ischemia reperfusion damage and anti-lipid peroxidation effects of paeonol in rat heart].
    Zhang WG; Zhang ZS
    Yao Xue Xue Bao; 1994; 29(2):145-8. PubMed ID: 8042513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Uptake of 67Ga in the heart of rats treated with isoproterenol.
    Sasaki T; Kojima S; Kubodera A
    Eur J Nucl Med; 1982; 7(12):545-8. PubMed ID: 6962065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Action of creatinol-O-phosphate and ouabain on automatic sinus activity in the isolated frog heart].
    Musso E; De Ambroggi L; Taccardi B
    Farmaco Prat; 1974 Nov; 29(11):629-35. PubMed ID: 4435202
    [No Abstract]   [Full Text] [Related]  

  • 48. A new mechanism of serum creatine phosphokinase elevation in strangulated small bowel obstruction: an experimental rat model.
    Mukai M; Tamaki T; Noto T; Tajima T; Nakano S; Mitomi T
    J Int Med Res; 1995; 23(3):184-90. PubMed ID: 7649342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Serum creatine phosphokinase activity: analysis of information provided by different ways of expressing the results].
    Marcilla de Parada NE; Río ME; Sanahuja JC
    Arch Latinoam Nutr; 1976 Jun; 26(2):161-76. PubMed ID: 821413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective effect of inosine on adrenaline-induced myocardial necrosis.
    Czarnecki A
    Pharmacol Res Commun; 1986 May; 18(5):459-69. PubMed ID: 3737656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical results and statistical analysis of the use of creatinol-O-phosphate].
    Breunig H
    Med Monatsschr; 1977 Nov; 31(11):526-9. PubMed ID: 337092
    [No Abstract]   [Full Text] [Related]  

  • 52. Protective effects of prostaglandin I2 analogues on CPK release in rat's heart-lung preparation.
    Kashimoto S; Nakamura T; Oguchi T; Kume M; Kumazawa T
    J Anesth; 1991 Oct; 5(4):359-62. PubMed ID: 15278604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ionic changes evoked by isoprenaline in rat hearts in vivo and in vitro and their reduction by creatinol O-phosphate.
    Godfraind T; Ghysel-Burton J; Sturbois X
    Arzneimittelforschung; 1979; 29(9a):1468-70. PubMed ID: 575494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The action of creatinol 0-phosphate on the inotropic effect of isoprenaline in isolated rat atria and in anesthetized dogs.
    Godfraind T; Ghysel-Burton J; Merlo L
    Arzneimittelforschung; 1979; 29(9a):1465-7. PubMed ID: 575493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Action of creatinol-O-phosphate on the contractility changes evoked by hypoxia and ischemia in rat isolated heart.
    Godfraind T; Saleh MM
    Arzneimittelforschung; 1984; 34(9):968-72. PubMed ID: 6542374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological and toxicological properties of creatinol O-phosphate. A review.
    Marzo A; Ghirardi P
    Arzneimittelforschung; 1979; 29(9a):1449-52. PubMed ID: 395957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective action of creatinol O-phosphate against serum CPK activity enhanced by isoprenaline in the rat.
    Marzo A; Ghirardi P
    Arzneimittelforschung; 1979; 29(9a):1471-3. PubMed ID: 575495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An analysis of the reduction by creatinol O-phosphate of the myocardial lesions evoked by isoprenaline in the rat.
    Godfraind T; Sturbois X
    Arzneimittelforschung; 1979; 29(9a):1457-64. PubMed ID: 575492
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.